Why proteomics is not the new genomics and the future of mass spectrometry in cell biology
- PMID: 27956468
- PMCID: PMC5223617
- DOI: 10.1083/jcb.201612010
Why proteomics is not the new genomics and the future of mass spectrometry in cell biology
Abstract
Mass spectrometry (MS) is an essential part of the cell biologist's proteomics toolkit, allowing analyses at molecular and system-wide scales. However, proteomics still lag behind genomics in popularity and ease of use. We discuss key differences between MS-based -omics and other booming -omics technologies and highlight what we view as the future of MS and its role in our increasingly deep understanding of cell biology.
© 2017 Sidoli et al.
Figures
References
-
- Balog J., Sasi-Szabó L., Kinross J., Lewis M.R., Muirhead L.J., Veselkov K., Mirnezami R., Dezső B., Damjanovich L., Darzi A., et al. . 2013. Intraoperative tissue identification using rapid evaporative ionization mass spectrometry. Sci. Transl. Med. 5:194ra93 10.1126/scitranslmed.3005623 - DOI - PubMed
-
- Gillet L.C., Navarro P., Tate S., Röst H., Selevsek N., Reiter L., Bonner R., and Aebersold R.. 2012. Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: A new concept for consistent and accurate proteome analysis. Mol. Cell. Proteomics. 11:O111.016717 10.1074/mcp.O111.016717 - DOI - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
